The evolving science of cancer: emerging approaches to prevention and early detection, and the advances reshaping treatment
This week on The Drive
The evolving science of cancer:
emerging approaches to prevention and early detection, and the advances reshaping treatment
In episode #412 of The Drive, Peter welcomes back Siddhartha Mukherjee, M.D., Ph.D., a physician, oncologist, researcher, and the Pulitzer Prize-winning author of The Emperor of All Maladies. Fifteen years after the book's publication, Sid examines what has changed in our understanding of cancer, from how it arises and why early detection remains difficult to the advances reshaping treatment. Sid then turns to what he calls regenerative failure, the declining ability of tissues to repair and replenish themselves with age, and what it could mean for how we approach longevity. They also discuss the potential of chemoprevention, metabolic interventions, and AI to transform how cancer is prevented and treated.
They also cover:
- What may be driving the rise of colorectal cancer in younger adults, and the dietary changes Sid recommends
- How genetic testing now captures hereditary cancer risk well beyond BRCA1 and BRCA2, and how that information could guide prevention
- How elevated insulin may help cancer cells resist treatment, and the trial Peter and Sid propose to test GLP-1 agonists alongside standard cancer therapy
- Why random mutations alone may not explain who develops cancer, and how inflammation can turn dormant mutated cells into active tumors
Get the full breakdown of the studies, insights, and actionable takeaways from this episode
Premium members get exclusive access to the full show notes, including:
Who stands to benefit from blood-based early detection tests, and the risks of using them broadly in the general population
What an AI analysis of tens of thousands of CT scans found about the thymus and the risk of cancer and autoimmune disease
How CAR T cell therapy produces durable cures in some blood cancers, and what has held it back against solid tumors
Why the location of a pancreatic tumor strongly shapes prognosis, and how KRAS inhibitors are changing the outlook for patients
We're Expanding our Physician Team
We are seeking an experienced physician to join our concierge-style practice—the only longevity practice trained in the philosophy of Dr. Peter Attia. In this role, you will focus primarily on providing Medicine 3.0-focused patient care, conducting comprehensive virtual visits, synthesizing biometric and clinical data, and creating personalized, prevention-focused treatment plans.
If you’re a physician who shares our vision for proactive, preventative, and personalized care, click the button below to learn more and apply.
Attia Medical 15511 W Highway 71, Ste. 110 c/o PMB 131 Bee Cave, TX 78738-2825